NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 32 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,298,800 | -59.2% | 7,250,000 | -59.2% | 0.03% | -63.2% |
| Q2 2023 | $15,442,987 | -28.2% | 17,750,000 | -28.3% | 0.08% | -30.3% |
| Q1 2023 | $21,519,892 | +34.7% | 24,750,000 | +38.2% | 0.11% | -6.0% |
| Q4 2022 | $15,972,145 | -13.4% | 17,908,000 | -12.3% | 0.12% | +4.5% |
| Q3 2022 | $18,449,000 | +4.4% | 20,408,000 | 0.0% | 0.11% | +29.1% |
| Q2 2022 | $17,663,000 | -5.1% | 20,408,000 | 0.0% | 0.09% | +68.6% |
| Q1 2022 | $18,622,000 | +104.6% | 20,408,000 | +106.0% | 0.05% | +240.0% |
| Q4 2021 | $9,103,000 | – | 9,908,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 46,391,000 | $42,604,000 | 1.32% |
| Lombard Odier Asset Management (Europe) Ltd | 171,980 | $15,871,000 | 0.70% |
| WOLVERINE ASSET MANAGEMENT LLC | 80,367,000 | $73,232,000 | 0.68% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,419,000 | $5,736,000 | 0.39% |
| LINDEN ADVISORS LP | 63,485,000 | $58,560,000 | 0.36% |
| Ionic Capital Management LLC | 3,000,000 | $2,771,000 | 0.35% |
| SSI INVESTMENT MANAGEMENT LLC | 5,859,000 | $5,354,000 | 0.31% |
| Verition Fund Management LLC | 33,485,000 | $30,766,000 | 0.22% |
| Nicholas Investment Partners, LP | 3,550,000 | $3,244,000 | 0.20% |
| TFG Asset Management GP Ltd | 3,000,000 | $2,769,000 | 0.17% |